These 20 women are 2018's Fiercest in the life sciences industry.
Read 2018's Fiercest Women in Life Sciences report!
ElectroCore received clearance from the FDA to expand the use of its noninvasive nerve stimulator device for the prevention of cluster headaches.
Medtronic plans to absorb Nutrino Health, a nutrition-focused data analytics company, and further integrate its work with its diabetes group.
MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.
Teva has begun a limited U.S. launch of its generic EpiPen, at the same price as Mylan’s own authorized generic launched almost two years ago.
Roche launched an in vitro diagnostic to detect tropomyosin receptor kinase proteins in cancer, with potential use in a range of solid tumor types.
A Chinese researcher has claimed to be the first to use CRISPR gene-editing tools on live, implanted human embryos, resulting in the birth of twins.
Keyto's program includes a smart breath sensor that detects when the body is in ketosis and a mobile app that provides recommendations.
A yearlong investigation into medical device safety found more than 1.7 million injuries and 83,000 deaths linked to cleared devices over 10 years.
A phase 3 trial of Vectura’s VR475 in patients with severe uncontrolled asthma has missed its primary endpoint.
Illumina Ventures led a €16 million round for Stilla Technologies, a Paris-based developer of digital PCR solutions for genetic analysis.